These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4237949)

  • 41. [Clinical trial of coenzyme A in hepatopathies].
    Magaraci G
    Minerva Med; 1976 Feb; 67(8):512-8. PubMed ID: 943732
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Thiomesterone and liver function].
    Pickert H
    Med Klin; 1968 Aug; 63(31):1222-6. PubMed ID: 5719699
    [No Abstract]   [Full Text] [Related]  

  • 43. [CLINICAL USE OF A NEW COMBINATION FOR THE PURPOSE OF HEPATO-BILIARY THERAPY].
    PASQUIER J; MESTRALLET G; SITE M
    Lyon Med; 1964 May; 211():1489-98. PubMed ID: 14151240
    [No Abstract]   [Full Text] [Related]  

  • 44. [Hepagrisevit forte in chronic liver diseases].
    Kollatz E; Kramer A; Schopper W; Siede W
    Med Klin; 1965 Dec; 60(50):2032-5. PubMed ID: 5331151
    [No Abstract]   [Full Text] [Related]  

  • 45. [Hepatoprotective drugs. Clinical results of the use of a sulfhydryl-methylating preparation].
    Rapino P; Marulli R; Rapex G; Della Lunga S; Sabatino P
    Minerva Med; 1982 Oct; 73(40):2853-60. PubMed ID: 7133498
    [No Abstract]   [Full Text] [Related]  

  • 46. [D-penicillamine therapy in liver diseases. Preliminary results in 44 cases].
    Alexander M; Wille G
    MMW Munch Med Wochenschr; 1974 Feb; 116(5):211-6. PubMed ID: 4205097
    [No Abstract]   [Full Text] [Related]  

  • 47. [Therapeutic trial of EU 2200].
    Bernard C; Drevet J
    Lyon Med; 1968 Jul; 219(28):81-8. PubMed ID: 5739511
    [No Abstract]   [Full Text] [Related]  

  • 48. [Immunosuppressive therapy of chronic aggressive hepatitis and primary biliary cirrhosis].
    Lampe K; Hüdepohl M; Schopen RD
    Med Klin; 1972 Apr; 67(15):527-34. PubMed ID: 5053009
    [No Abstract]   [Full Text] [Related]  

  • 49. [Effects of administration of arginine thiazolidinecarboxylate in liver pathology of various origins. Results of a multicenter study].
    Gasbarrini G; Bernardi M
    Minerva Dietol Gastroenterol; 1982; 28(2):143-52. PubMed ID: 7099448
    [No Abstract]   [Full Text] [Related]  

  • 50. [Our experience with long-term therapy of chronic liver diseases using Superanabolon Spofa].
    Svacinka P; Horký J; Blahníková L
    Vnitr Lek; 1970 Dec; 16(12):1181-7. PubMed ID: 5491517
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of cirrhosis of the liver by a combination of Lipovitan and orotic acid (author's transl)].
    Fassati P; Spízek J; Fassati M
    Cas Lek Cesk; 1980 Jul; 119(27-28):770-3. PubMed ID: 7428000
    [No Abstract]   [Full Text] [Related]  

  • 52. Levamisole therapy in chronic active liver diseases.
    Piccari GG; Sarti F; D'imperio N; Formica G; Milandri M; Soffritti M; Dal Monte PR
    Acta Gastroenterol Belg; 1978; 41(5-6):356-62. PubMed ID: 707023
    [No Abstract]   [Full Text] [Related]  

  • 53. [Use of a titrated extract of Centella asiatica in chronic hepatic disorders (author's transl)].
    Darnis F; Orcel L; de Saint-Maur PP; Mamou P
    Sem Hop; 1979 Nov 8-15; 55(37-38):1749-50. PubMed ID: 230597
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.
    Elkington SG; Floch MH; Conn HO
    N Engl J Med; 1969 Aug; 281(8):408-12. PubMed ID: 4894464
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical experimentation with a new hepatotropic agent, EU 2200].
    Linquette M; Decoulx M
    Lille Med; 1966 Nov; 11(9):1051-5. PubMed ID: 5994072
    [No Abstract]   [Full Text] [Related]  

  • 56. [Clinico-statistical study of the therapeutic activity of coenzyme A in various hepatopathies].
    Ruberti A; Tobaldin G; Montanari MG; Castellani P
    Clin Ter; 1971 May; 57(4):309-42. PubMed ID: 5110947
    [No Abstract]   [Full Text] [Related]  

  • 57. [Clinical study of the effect of the administration of cathergen preparation in patients with chronic hepatic lesions].
    Maleev A; Tsvetkova V; Krŭstev Z; Kostova N; Lukanov L
    Vutr Boles; 1985; 24(5):39-43. PubMed ID: 4090451
    [No Abstract]   [Full Text] [Related]  

  • 58. Glucocorticoids in liver diseases.
    Quaade F
    Acta Med Scand Suppl; 1969; 500():49-54. PubMed ID: 5270161
    [No Abstract]   [Full Text] [Related]  

  • 59. [Action of lysine on the hyperammoniema of the cirrhotic patient].
    Lemonnier F; Goutand G; Caroli J
    Presse Med (1893); 1971 May; 7(23):1063-6. PubMed ID: 5577943
    [No Abstract]   [Full Text] [Related]  

  • 60. [Clinical investigation of silymarin in chronic liver diseases (author's transl)].
    Realini S; Gonvers JJ; Hofstetter JR
    Schweiz Rundsch Med Prax; 1975 May; 64(19):595-8. PubMed ID: 51497
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.